Photo via The Straits Times

Testosterone scripts for women rise, along with denials and delays

Read the original at The Straits Times ↗
Cite

The Straits Times. (2026, September 15). Testosterone scripts for women rise, along with denials and delays. The Straits Times. https://www.straitstimes.com/world/testosterone-scripts-for-women-rise-along-with-denials-and-delays

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

The Straits Times · collected 2026-09-15 · by The Straits Times

Quick Summary

Women are increasingly seeking testosterone therapy to manage menopause symptoms, but many face prescription delays and denials at pharmacies due to the lack of U.S.-approved testosterone products for women. According to a Reuters analysis by Truveta, prescriptions for women nearly tripled from January 2023 to July 2026, despite limited medical evidence supporting its use beyond treating hypoactive sexual desire disorder. The FDA is holding a public workshop on Thursday to review the evidence for testosterone use in menopausal women, highlighting concerns about safety and efficacy for off-label uses like fatigue and muscle loss.
Written by AI on 2026-09-16, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Women are increasingly seeking testosterone therapy to manage symptoms of menopause, such as fatigue and loss of muscle strength, but they often face prescription delays and denials at pharmacies. Despite the rise in off-label use, there is no U.S.-approved testosterone product for women, primarily due to a lack of medical guidance beyond its approved use for treating persistently low sexual desire related to menopause. The Menopause Society and other medical organizations only support using testosterone for hypoactive sexual desire disorder in menopausal women. Dr. Stephanie Faubion, director of Mayo Clinic's Center for Women's Health and medical director of The Menopause Society, stated that there is no evidence that testosterone improves muscle mass, bone density, or mood in women.

Written for “Testosterone Treatments Controversy” on 2026-11-21, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 8% of its claims. Each row says how that neighbour differs.
The Hindu
Hedges 2 of 6 claims Outlet record 60/100
“The articles discuss different programs regarding testosterone use, one focusing on prescription delays and denials for women seeking off-label therapy in civilian settings, while the other reports on a Pentagon program for mandatory testing among U.S. service members.”
ABC News (US)
Hedges 2 of 19 claims Outlet record 66/100
“The articles discuss related topics but describe different events: one focuses on prescription delays and denials for testosterone therapy for menopause symptoms among patients and clinicians, while the other reports on an FDA public workshop examining long-term safety concerns of off-label testosterone use.”

Story

Testosterone Treatments Controversy
Health · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
38
sentences that state something as happening or true
Uncertain
8%
3 of 38 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
The Straits Times's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-16 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Straits Times · 5634 article(s) · 7 correction(s) detected
Running correction rate · 7 correction(s)

Who wrote this

The Straits Times
3888 article(s) here · 1 carrying a prediction
He told groups of subordinates that they had become so rich that he couldn’t motivate them simply with money, according to three people who spoke on the condition of anonymity to discuss confidential conversations.
The closed freeway lanes recall stems from unusual circumstances where a Waymo vehicle may enter and continue driving in a closed freeway lane, the company said, adding it is still working on the recall remedy.
Araqchi says Iran wants diplomacy to end war; Trump says terms unacceptable Nov 20 - Iran's Foreign Minister Abbas Araqchi said Tehran still hoped diplomacy could end its war with the United States, while US President Donald Trump said Iran wanted a deal but one that was not acceptable to him.
While You Were Sleeping: 5 stories you might have missed, Nov 21, 2026 Trump, Xi agree military AI decisions should involve humans US President Donald Trump and Chinese President Xi Jinping agreed humans should always be involved in military decisions that use artificial intelligence technologies, even as the two countries compete for AI supremacy, Treasury Secretary Scott Bessent said on Nov 20.
US Vice President Vance declines to say he would have ordered Iran strikes WASHINGTON, Nov 20 - US Vice President JD Vance on Friday declined to say whether he would have authorized strikes on Iran to prevent the country from developing a nuclear weapon, sidestepping President Donald Trump's calls for him to say the attacks were necessary and that he would carry them out again.
Some would blame Ottawa for the trade conflict while others pointed the finger at Washington.
Whoever wins will have to tackle multiple crises, including several wars, cutbacks in US contributions to the UN, and the 193-member body's declining political relevance as Washington has pulled out of dozens of its agencies.
I don’t think any human was about to find this,” Conrey said, adding that he believed “there will be simpler ways to do it.” The Riemann Hypothesis is one of seven Millennium Prize Problems selected by the Clay Mathematics Institute in 2000, which offers US$1 million (S$1.28 million) for a solution to each. Under the institute’s rules, a solution must be published in a peer-reviewed journal and withstand two years of scrutiny.
If the hearing proceeds as planned, it would mark Huang's first public testimony since stepping down as Nvidia's chief executive on November 12.
Denmark’s foreign minister on Nov 20 said Moscow’s defence attache in Copenhagen would be expelled after Russia was suspected of being behind an attempted assassination of a Ukrainian rapper.
Also by The Straits Times
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 3888 articles by The Straits Times →

Topics

Center for Women's Health FDA Mayo Clinic's The Menopause Society U.S.-approved

Subjects

Amazon Pharmacy ORG · 2× FDA ORG · 2× Lanoff PERSON · 2× Reuters ORG · 2× The Menopause Society ORG · 2× Center for Women's Health ORG · 1× Mayo Clinic's ORG · 1× Stephanie Faubion PERSON · 1× Truveta ORG · 1× U.S.-approved GPE · 1×

Narrative

Some clinicians are also prescribing it for menopause-related symptoms such as fatigue and loss of muscle strength, despite a lack of medical guidance for that use. The Menopause Society and half a dozen other medical organizations only back testosterone use for hypoactive sexual desire disorder in menopausal women. "We do not have any evidence in women that it will improve muscle mass or bone density or mood or well-being or really any other metric," said Dr. Stephanie Faubion, director of Mayo Clinic's Center for Women's Health and medical director of The Menopause Society.
framing: assertive · carried by 1 article(s) · first seen 2026-09-16
Some clinicians are also prescribing it for menopause-related symptoms such as fatigue and loss of muscle strength, despite a lack of medical guidance for that use. The Menopause Society and half a dozen other medical organizations only back testosterone use for hypoactive sexual desire disorder in menopausal women. "We do not have any evidence in women that it will improve muscle mass or bone density or mood or well-being or really any other metric," said Dr. Stephanie Faubion, director of Mayo Clinic's Center for Women's Health and medical director of The Menopause Society.
2026-09-16 · The Straits Times
Testosterone scripts for women rise, along with denials and delays · assertive framing

Claims (38 extracted, 3 hedged)

Testosterone scripts for women rise, along with denials and delays Sept 15 - Women increasingly turning to testosterone therapy to manage menopause symptoms are running into unexpected prescription delays and denials at pharmacies, according to interviews with more than half a dozen doctors, nurses and patients. uncertain
Women → rise → doctors
There is no U.S.-approved testosterone product for women, although its off-label use is on the rise, primarily to treat persistently low sexual desire related to menopause, the only condition for which medical guidelines and evidence of efficacy currently exist. asserted
guidelines → be → efficacy
Some clinicians are also prescribing it for menopause-related symptoms such as fatigue and loss of muscle strength, despite a lack of medical guidance for that use. The Menopause Society and half a dozen other medical organizations only back testosterone use for hypoactive sexual desire disorder in menopausal women. "We do not have any evidence in women that it will improve muscle mass or bone density or mood or well-being or really any other metric," said Dr. Stephanie Faubion, director of Mayo Clinic's Center for Women's Health and medical director of The Menopause Society. asserted
Faubion → prescribe → Society
"What testosterone is being touted for in the lay public and on social media is not really what we have data for," she said. asserted
she → tout → data
Testosterone's rise comes as more women turn to hormone therapy overall, also driven by social media and, more recently, by the FDA, which backed estrogen and progesterone use for menopause symptoms as safe and effective. asserted
which → come → symptoms
Some clinicians prescribe testosterone alongside these therapies. asserted
clinicians → prescribe → therapies
An exclusive data analysis for Reuters by healthcare analytics firm Truveta shows the rate of women receiving a testosterone prescription jumped 146%, nearly tripling, from January 2023 to July 2026. asserted
rate → show → July
The U.S. Food and Drug Administration will hold a public workshop on Thursday to review evidence for testosterone use in menopausal women, which has been promoted by Health Secretary Robert F. Kennedy Jr. and Defense Secretary Pete Hegseth, who has made an issue of testosterone levels among the troops. asserted
who → hold → troops
While healthcare providers can prescribe approved medicines any way they see fit, an FDA spokesperson said these off-label uses have not been evaluated by the agency for safety, efficacy or dosing. asserted
uses → prescribe → safety
WORKAROUNDS FOR WOMEN With no approved testosterone for women, patients must divide packaged versions designed for men often at many times the doses they're seeking. Jennifer Lanoff, a women's health nurse practitioner in Washington, D.C., said Amazon Pharmacy rejected prescriptions from her practice for the first time this year. asserted
Pharmacy → approve → time
"We've done (off-label testosterone prescriptions) forever. asserted
We → do → prescriptions
It's clinical guidelines recommended. asserted
It → recommend → ?
Amazon has not given us a problem before," she said. asserted
she → give → problem
"I don't know exactly what happened or why they rejected. asserted
they → know → ?
They say it was a new policy." asserted
it → say → ?
Lanoff said she has had some success rewriting prescriptions under which patients discard leftover gel rather than splitting doses for later use. asserted
patients → say → use
Amazon Pharmacy said it does not dispense some testosterone prescriptions that require women to customize doses in order to ensure safe and compliant dispensing. asserted
that → say → dispensing
It added that the policy is not specific to testosterone or based on a patient's sex or gender identity. asserted
policy → add → identity
The company said it refers customers to compounding pharmacies that mix ingredients for specialized doses. asserted
that → say → doses
Compounded testosterone can cost about $100 for a three-month supply compared with $30 after discounts for a 10-month supply at a commercial pharmacy, Lanoff said. asserted
Lanoff → cost → pharmacy
Most insurance companies do not cover testosterone for women, the doctors, nurses and patients said. asserted
doctors → cover → women
Magen Price, a nurse practitioner and founder of Mystic Valley Sexual Wellness, said more than one-third of the 80 patients in her practice who currently use testosterone have encountered issues with their prescriptions, including at CVS and Walgreens pharmacies. asserted
who → say → pharmacies
The issues that began last year have worsened, Price told Reuters. asserted
Price → begin → Reuters
When Amy Swan, a 55-year-old graphic designer outside Boston, tried to fill her first testosterone gel prescription in March, she expected a simple pharmacy visit. asserted
she → try → visit
Instead, she spent weeks trying to get a pharmacy to honor a GoodRx discount coupon that would reduce the cost by 25%. asserted
that → spend → %
"Hours of my time were lost just being able to get this one prescription," Swan said. asserted
Swan → lose → prescription
CVS said its pharmacies regularly fill prescriptions for topical testosterone gel for women. asserted
pharmacies → say → women
Other retailers with large pharmacies including Walgreens, Costco and Walmart did not respond to requests for comment. asserted
retailers → include → comment
Kroger declined to comment. asserted
Kroger → decline → ?
Kevin Schipper, a pharmacist and director of product lifecycle management at consulting firm ProPharma, said pharmacies may decline prescriptions due to concerns over dosing accuracy and medication safety, as well as stability, storage and contamination if single-use packaging is opened and reused. uncertain
packaging → consult → accuracy
Because it is a controlled substance — similar to aspirin with codeine — each state also has record-keeping requirements for the government. asserted
state → control → government
TRIALS FOR SAFETY Over 30 trials studying testosterone use for various health conditions in women are underway or planned, according to ClinicalTrials.gov, including a Marius Pharmaceuticals-sponsored sexual dysfunction trial due to start as soon as later this year. uncertain
trials → study → year
Aviva Bio is developing a next-generation testosterone product that would address breast cancer risk associated with use of the hormone. asserted
that → develop → hormone
Products currently used by women include branded and generic testosterone gels, such as AbbVie's AndroGel, Keenova Therapeutics' Testim and Upsher-Smith's Vogelxo. asserted
Products → use → AndroGel
Upsher-Smith declined to comment on whether it plans to develop testosterone products specifically for women. asserted
it → decline → women
AbbVie and Keenova did not respond to requests for comment. asserted
AbbVie → respond → comment
Cynthia Stuenkel, a clinical professor of medicine at the University of California, San Diego, said she hopes the FDA will prioritize evaluating a testosterone product designed for women. asserted
FDA → say → women
"This would certainly ease the ability of clinicians to more confidently prescribe testosterone and for women to more easily and confidently use testosterone specifically dosed for them," she said. asserted
she → ease → them
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support